Kidswell Bio Corporation (TYO:4584)
Japan · Delayed Price · Currency is JPY 160.00
-5.00 (-3.03%)
Sep 16, 2026, 3:30 PM JST
Kidswell Bio Market Cap
Kidswell Bio has a market cap or net worth of 8.09 billion as of September 15, 2026. Its market cap has decreased by -34.16% in one year.
Market Cap
8.09B
Enterprise Value
7.34B
Revenue
6.14B
Ranking
n/a
PE Ratio
n/a
Stock Price
160.00
ChartMarket Cap Chart
Since November 30, 2012, Kidswell Bio's market cap has increased from 2.73B to 8.09B, an increase of 196.08%. That is a compound annual growth rate of 8.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 8.09B | -19.63% |
| Dec 30, 2025 | 10.07B | 125.16% |
| Dec 30, 2024 | 4.47B | -11.75% |
| Dec 29, 2023 | 5.07B | -40.50% |
| Dec 30, 2022 | 8.52B | -45.05% |
| Dec 30, 2021 | 15.50B | 7.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OncoTherapy Science | 9.39B |
| K Pharma,Inc. | 9.37B |
| Carna Biosciences | 9.03B |
| Nano Holdings | 8.94B |
| CellSeed | 8.75B |
| J-Pharma | 8.40B |
| BrightPath Biotherapeutics | 7.92B |
| StemCell Institute | 7.53B |